News
First weight-loss pill from Lilly shows promising results
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose weight. The company is hoping to bring the first GLP-1 weight-loss pill to market, The Wall Street Journal said.
The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...
Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind ...
In the Phase 3 test, which included over 1,400 participants, the overall occurrences of liver trouble were in line with other weight-loss drugs that have already been approved. However ...
Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback